selected publications
- PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia. Cancers. 2023 Academic Article GET IT
- Genome Editing for Engineering the Next Generation of Advanced Immune Cell Therapies. Advances in experimental medicine and biology. 2023 Academic Article GET IT
-
Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer.
Immunotherapy advances.
2022
Review
GET IT
Times cited: 8 -
Strategies to Enhance the Therapeutic Efficacy, Applicability, and Safety of Genetically Engineered Immune Cells.
Critical reviews in immunology.
2021
Review
GET IT
Times cited: 4 -
Viral metagenomics in blood donations with post-donation illness reports from Brazil.
Blood transfusion = Trasfusione del sangue.
2020
Academic Article
GET IT
Times cited: 7 -
Two Functional Variants of AP-1 Complexes Composed of either γ2 or γ1 Subunits Are Independently Required for Major Histocompatibility Complex Class I Downregulation by HIV-1 Nef.
Journal of virology.
2020
Academic Article
GET IT
Times cited: 10 -
Molecular prevalence and genotypes of human pegivirus-1 (HPgV-1) and SENV-like viruses among multiply transfused patients with beta-thalassemia.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
2019
Academic Article
GET IT
Times cited: 3 -
Human pegivirus-1 (HPgV-1) RNA prevalence and genotypes in volunteer blood donors from the Brazilian Amazon.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
2019
Academic Article
GET IT
Times cited: 10 -
Human pegivirus-1 (HPgV-1, GBV-C) RNA prevalence and genotype diversity among volunteer blood donors from an intra-hospital hemotherapy service in Southern Brazil.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
2019
Academic Article
GET IT
Times cited: 14